Drugs / n-3PUFAs Treatment
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04664816 | Dec 2020 → Dec 2022 | urinary bladder carcinoma | Mansoura University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | n-3PUFAs Treatment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04664816 ↗ |
| Known as | n-3 PUFAs | “omega-3 polyunsaturated fatty acids (n-3 PUFAs)” NCT04664816 ↗ |
| Route | Oral | “1200 mg) orally, twice a day” NCT04664816 ↗ |